“Can you tell me again how you are related to the patient?” Sangeeta Patil of the Malpa Dongri municipal school, one of the 50-odd teachers staffing the Covid-19 war room in Mumbai’s K-East ward, repeats herself over the telephone.
On Nov. 9, American pharmaceutical giant Pfizer and partner BioNTech announced an interim analysis of late-stage trials of their coronavirus vaccine candidate. The company said early results showed that trial volunteers who received the vaccine experienced 90% fewer cases of symptomatic Covid-19 than volunteers who received a placebo. These data have not been published in a peer-reviewed medical journal.
The first confirmed case of Covid-19 reinfection was reported by researchers at the University of Hong Kong in the last week of August. A few other anecdotal cases of reinfection have since emerged, including one from Bengaluru.
In 2010, novelist and newspaper columnist Nilanjana Roy argued that the dosa is the closest thing India has to a national dish. We now know this is true, because nothing has mobilised more vom emojis than news that McDonald’s India has come up with a “masala dosa burger,” which launched this weekend. Did we see all this outrage for the birizza?
Exploring the way stocks were bought and sold before online trading changed everything.
